{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:52:21Z","timestamp":1782226341775,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"DOI":"10.1186\/s12875-026-03195-8","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T04:46:18Z","timestamp":1770007578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Incidence of hyperkalaemia and major creatinine elevation after renin\u2013angiotensin system inhibitor initiation in a Singapore primary care cohort"],"prefix":"10.1186","volume":"27","author":[{"given":"Michael Warren","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sz\u00fccs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desmond","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie C. C.","family":"Van Der Lubbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"3195_CR1","unstructured":"Mancia G, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A et al. ESC\/ESH Guidelines for the management of arterial hypertension. 2018;39(33):3021\u2013104."},{"issue":"3","key":"3195_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2020.11.003","volume":"99","author":"AK Cheung","year":"2021","unstructured":"Cheung AK, Chang TI, Cushman WC, Furth SL, Hou FF, Ix JH, et al. KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021;99(3):S1\u201387.","journal-title":"Kidney Int"},{"key":"3195_CR3","volume-title":"Chronic kidney disease: assessment and management (2021) NICE guideline NG203","author":"National Institute for Health and Care Excellence (NICE)","year":"2021","unstructured":"National Institute for Health and Care Excellence (NICE). Chronic kidney disease: assessment and management (2021) NICE guideline NG203. London: National Institute for Health and Care Excellence (NICE); 2021."},{"issue":"6","key":"3195_CR4","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJMra035279","volume":"351","author":"BF Palmer","year":"2004","unstructured":"Palmer BF. Managing hyperkalaemia caused by inhibitors of the Renin\u2013Angiotensin\u2013Aldosterone system. N Engl J Med. 2004;351(6):585\u201392.","journal-title":"N Engl J Med"},{"issue":"3","key":"3195_CR5","doi-asserted-by":"publisher","first-page":"e156","DOI":"10.1111\/j.1755-5922.2010.00258.x","volume":"30","author":"MA Raebel","year":"2012","unstructured":"Raebel MA. Hyperkalemia associated with use of angiotensin-Converting enzyme inhibitors and angiotensin receptor blockers: hyperkalemia with ACEI and ARB. Cardiovasc Ther. 2012;30(3):e156\u201366.","journal-title":"Cardiovasc Ther"},{"key":"3195_CR6","doi-asserted-by":"crossref","unstructured":"Pfeffer MA, K\u00f8ber L, de Werf FV, Edwards S. Valsartan, Captopril, or both in myocardial infarction complicated by heart Failure, left ventricular Dysfunction, or both. N Engl J Med. 2003;349(20):1893\u2013906.","DOI":"10.1056\/NEJMoa032292"},{"issue":"10","key":"3195_CR7","first-page":"685","volume":"3","author":"SOLVDI The","year":"1992","unstructured":"The SOLVDI. Effect of Enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;3(10):685\u201391.","journal-title":"N Engl J Med"},{"issue":"3","key":"3195_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2215\/CJN.07821109","volume":"5","author":"MR Weir","year":"2010","unstructured":"Weir MR, Rolfe M. Potassium homeostasis and Renin-Angiotensin-Aldosterone system inhibitors. Clin J Am Soc Nephrol. 2010;5(3):531\u201348.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"3195_CR9","doi-asserted-by":"publisher","first-page":"e005428","DOI":"10.1161\/JAHA.116.005428","volume":"6","author":"G Bandak","year":"2017","unstructured":"Bandak G, Sang Y, Gasparini A, Chang AR, Ballew SH, Evans M, et al. Hyperkalemia after initiating Renin\u2013Angiotensin system blockade: the Stockholm creatinine measurements (SCREAM) project. J Am Heart Assoc. 2017;6(7):e005428.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"3195_CR10","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1093\/ndt\/gfz263","volume":"36","author":"JB Wetmore","year":"2021","unstructured":"Wetmore JB, Yan H, Horne L, Peng Y, Gilbertson DT. Risk of hyperkalemia from renin\u2013angiotensin\u2013aldosterone system inhibitors and factors associated with treatment discontinuities in a real-world population. Nephrol Dial Transpl. 2021;36(5):826\u201339.","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"3195_CR11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.7326\/M16-2966","volume":"19","author":"S Beddhu","year":"2017","unstructured":"Beddhu S, Rocco MV, Toto R, Craven TE, Greene T, Bhatt U, et al. Effects of intensive systolic blood pressure control on kidney and cardiovascular outcomes in persons without kidney disease: A secondary analysis of a randomized trial. Ann Intern Med. 2017;19(6):375.","journal-title":"Ann Intern Med"},{"issue":"4","key":"3195_CR12","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/HYPERTENSIONAHA.121.16505","volume":"78","author":"AH Hu","year":"2021","unstructured":"Hu AH, Chang TI. SPRINT\u2014A Kidney-Centric narrative review: recent advances in hypertension. Hypertension. 2021;78(4):946\u201354.","journal-title":"Hypertension"},{"issue":"6","key":"3195_CR13","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1161\/HYPERTENSIONAHA.118.11944","volume":"72","author":"D Collard","year":"2018","unstructured":"Collard D, Brouwer TF, Peters RJG, Vogt L, Van Den Born BJH. Creatinine rise during blood pressure therapy and the risk of adverse clinical outcomes in patients with type 2 diabetes mellitus: A post hoc analysis of the ACCORD-BP randomized controlled trial. Hypertension. 2018;72(6):1337\u201344.","journal-title":"Hypertension"},{"issue":"16","key":"3195_CR14","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1056\/NEJMra020676","volume":"347","author":"BF Palmer","year":"2002","unstructured":"Palmer BF. Renal dysfunction complicating the treatment of hypertension. N Engl J Med. 2002;347(16):1256\u201361.","journal-title":"N Engl J Med"},{"issue":"6","key":"3195_CR15","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1097\/00000441-200106000-00005","volume":"321","author":"NM Kaplan","year":"2001","unstructured":"Kaplan NM, Palmer BF, Palmer BF. Impaired renal autoregulation: implications for the genesis of hypertension and hypertension-Induced renal injury. Am J Med Sci. 2001;321(6):388\u2013400.","journal-title":"Am J Med Sci"},{"issue":"19","key":"3195_CR16","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","volume":"288","author":"JT Wright","year":"2002","unstructured":"Wright JT, Bakris G, Greene T, Agodoa LY, Appel LJ, Rostand SG. Effect of blood pressure Lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. J Am Med Assoc. 2002;288(19):2421\u201331.","journal-title":"J Am Med Assoc"},{"key":"3195_CR17","doi-asserted-by":"crossref","unstructured":"Schmidt M, Mansfield KE, Bhaskaran K, Nitsch D, S\u00f8rensen HT, Smeeth L et al. Serum creatinine elevation after renin-angiotensin system Blockade and long term cardiorenal risks: cohort study. BMJ. 2017;356:j791.","DOI":"10.1136\/bmj.j791"},{"issue":"9","key":"3195_CR18","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.2215\/CJN.03060319","volume":"14","author":"EL Fu","year":"2019","unstructured":"Fu EL, Trevisan M, Clase CM, Evans M, Lindholm B, Rotmans JI, et al. Association of acute increases in plasma creatinine after Renin-Angiotensin Blockade with subsequent outcomes. Clin J Am Soc Nephrol. 2019;14(9):1336\u201345.","journal-title":"Clin J Am Soc Nephrol"},{"key":"3195_CR19","unstructured":"National Population and Talent Division, Group S. Prime Minister\u2019s Office, Singapore Department of Statistics, Ministry of Home Affairs, Immigration & Checkpoints Authority, Ministry of Manpower. Population in Brief 2024 [Internet]. Government of Singapore; 2024. Available from: https:\/\/www.strategygroup.gov.sg\/files\/media-centre\/publications\/Population_in_Brief_2024.pdf"},{"key":"3195_CR20","first-page":"101138","volume":"49","author":"RSJ Goh","year":"2024","unstructured":"Goh RSJ, Chong B, Jayabaskaran J, Jauhari SM, Chan SP, Kueh MTW, et al. The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, central Asia, and high-income Asia Pacific regions. Lancet Reg Health - West Pac. 2024;49:101138.","journal-title":"Lancet Reg Health - West Pac"},{"issue":"9","key":"3195_CR21","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3109\/0886022X.2012.717478","volume":"34","author":"T Yildirim","year":"2012","unstructured":"Yildirim T, Arici M, Piskinpasa S, Aybal-Kutlugun A, Yilmaz R, Altun B, et al. Major barriers against Renin\u2013Angiotensin\u2013Aldosterone system blocker use in chronic kidney disease stages 3\u20135 in clinical practice: A safety concern? Ren Fail. 2012;34(9):1095\u20139.","journal-title":"Ren Fail"},{"issue":"6","key":"3195_CR22","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/MAJ.0000000000000475","volume":"349","author":"S Shirazian","year":"2015","unstructured":"Shirazian S, Grant CD, Mujeeb S, Sharif S, Kumari P, Bhagat M, et al. Underprescription of Renin\u2013Angiotensin system blockers in moderate to severe chronic kidney disease. Am J Med Sci. 2015;349(6):510\u20135.","journal-title":"Am J Med Sci"},{"issue":"1","key":"3195_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.kint.2019.09.018","volume":"97","author":"CM Clase","year":"2020","unstructured":"Clase CM, Carrero JJ, Ellison DH, Grams ME, Hemmelgarn BR, Jardine MJ, et al. Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2020;97(1):42\u201361.","journal-title":"Kidney Int"},{"key":"3195_CR24","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021 Sept 21;42(36):3599\u2013726."},{"key":"3195_CR25","doi-asserted-by":"crossref","unstructured":"Levey AS, Stevens LA, Schmid CH, Iii AFC, Feldman HI, Kusek JW et al. A New Equation to Estimate Glomerular Filtration Rate. Ann Intern Med. 2009;150(9):604\u201312.","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"3195_CR26","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing [Internet]. Vienna, Austria. 2024. Available from: https:\/\/www.R-project.org\/"},{"issue":"43","key":"3195_CR27","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham H, Averick M, Bryan J, Chang W, McGowan L, Fran\u00e7ois R, et al. Welcome to the tidyverse. J Open Source Softw. 2019;4(43):1686.","journal-title":"J Open Source Softw"},{"key":"3195_CR28","unstructured":"Pattaro C, Fujii R, Herold J, nephro. Utilities for Nephrology [Internet]. 2023. Available from: https:\/\/CRAN.R-project.org\/package=nephro"},{"issue":"1","key":"3195_CR29","doi-asserted-by":"publisher","first-page":"570","DOI":"10.32614\/RJ-2021-053","volume":"13","author":"DD Sjoberg","year":"2021","unstructured":"Sjoberg DD, Whiting K, Curry M, Lavery JA, Larmarange J. Reproducible summary tables with the Gtsummary package. R J. 2021;13(1):570.","journal-title":"R J"},{"issue":"9","key":"3195_CR30","doi-asserted-by":"publisher","first-page":"e006415","DOI":"10.1161\/CIRCOUTCOMES.119.006415","volume":"13","author":"RV Parikh","year":"2020","unstructured":"Parikh RV, Nash DM, Brimble KS, Markle-Reid M, Tan TC, McArthur E, et al. Kidney function and potassium monitoring after initiation of Renin-Angiotensin-Aldosterone system Blockade therapy and outcomes in 2 North American populations. Circ Cardiovasc Qual Outcomes. 2020;13(9):e006415.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"3195_CR31","doi-asserted-by":"publisher","first-page":"e012818","DOI":"10.1136\/bmjopen-2016-012818","volume":"7","author":"M Schmidt","year":"2017","unstructured":"Schmidt M, Mansfield KE, Bhaskaran K, Nitsch D, S\u00f8rensen HT, Smeeth L, et al. Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin\u2013angiotensin system blockade: a UK general practice-based cohort study. BMJ Open. 2017;7(1):e012818.","journal-title":"BMJ Open"},{"issue":"1","key":"3195_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2337\/cd23-as01","volume":"41","author":"American Diabetes Association","year":"2023","unstructured":"American Diabetes Association. Standards of care in Diabetes\u20142023 abridged for primary care providers. Clin Diabetes. 2023;41(1):4\u201331.","journal-title":"Clin Diabetes"},{"issue":"1","key":"3195_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/bcp.13434","volume":"84","author":"A Al-Naher","year":"2018","unstructured":"Al-Naher A, Wright D, Devonald MAJ, Pirmohamed M. Renal function monitoring in heart failure - what is the optimal frequency? A narrative review: frequency of renal monitoring in heart failure. Br J Clin Pharmacol. 2018;84(1):5\u201317.","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"3195_CR34","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1007\/s00394-023-03128-6","volume":"62","author":"C Reddin","year":"2023","unstructured":"Reddin C, Ferguson J, Murphy R, Clarke A, Judge C, Griffith V, et al. Global mean potassium intake: a systematic review and bayesian meta-analysis. Eur J Nutr. 2023;62(5):2027\u201337.","journal-title":"Eur J Nutr"},{"key":"3195_CR35","unstructured":"Singapore Department of Statistics. Resident Population of Other Ethnic Groups by Age Group, Ethnic Group and Sex (General Household Survey 2015). data.gov.sg; 2023 [cited 2025 Dec 20]. Available from: https:\/\/data.gov.sg\/datasets\/d_5d80697df3d471b7c4ae4d0a60030368\/view"},{"issue":"3","key":"3195_CR36","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/pds.1923","volume":"19","author":"ES Johnson","year":"2010","unstructured":"Johnson ES, Weinstein JR, Thorp ML, Platt RW, Petrik AF, Yang X, et al. Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril: PREDICTING THE RISK OF HYPERKALEMIA IN CKD. Pharmacoepidemiol Drug Saf. 2010;19(3):266\u201372.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"3195_CR37","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000013599","volume":"20","author":"TS Ahuja","year":"2000","unstructured":"Ahuja TS, Freeman D Jr., Mahnken JD, Agraharkar M, Siddiqui M, Memon A. Predictors of the development of hyperkalemia in patients using Angiotensin-Converting enzyme inhibitors. Am J Nephrol. 2000;20(4):268\u201372.","journal-title":"Am J Nephrol"}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-026-03195-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-026-03195-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-026-03195-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:03:50Z","timestamp":1772582630000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12875-026-03195-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3195"],"URL":"https:\/\/doi.org\/10.1186\/s12875-026-03195-8","relation":{},"ISSN":["2731-4553"],"issn-type":[{"value":"2731-4553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was exempt from ethical review by the institutional Domain Specific Review Board (DSRB Reference 2023\/01018).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}